INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP) Files An 8-K Submission of Matters to a Vote of Security Holders

INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

Item 5.07 Submission of Matters to a Vote of Security Holders

On November 28, 2016, the Company held its 2016 Annual Meeting of
Shareholders (the Annual Meeting). A total of 21,105,174 shares
of the Companys common stock, par value $0.002 per share, were
entitled to vote as of the close of business on October 14, 2015,
the record date for the Annual Meeting. The holders of 17,466,360
shares of common stock, a majority, were present in person or
represented by proxy at the Annual Meeting, at which the
shareholders were asked to vote on two proposals. The proposals
are described in detail in the Companys definitive proxy
materials which were filed with the Securities and Exchange
Commission and first made available to shareholders on or about
October 28, 2016. Set forth below is the matters acted upon by
the Companys shareholders at the Annual Meeting, and the final
voting results of each such proposal.

Proposal No. 1
Non-Binding Advisory Vote on Executive
Compensation

The Companys shareholders adopted a non-binding, advisory
resolution approving the compensation paid to the Companys named
executive officers. The final voting results were as follows:

Broker

For

Against

Abstain

Non-Votes

12,983,887

465,711

6,375

3,122,453

Proposal No. To ratify the appointment
of the Companys independent auditors for the fiscal year ending
June 30, 201

The Companys shareholders voted in favor of ratifying the
appointment of Friedman, LLP as the Companys independent auditors
for the fiscal year ending June 30, 2017. The final voting
results were as follows:

For

Against

Abstain

16,501,571

51,001

25,854


About INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP)

Integrated Biopharma Inc. is engaged in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s business segments include Contract Manufacturing operated by InB:Manhattan Drug Company, Inc.(MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and healthcare providers; Branded Proprietary Products operated by AgroLabs, Inc. (AgroLabs), which distributes nutritional products for sale through market, grocery, drug and vitamin retailers, under the brands of Naturally Noni, Coconut Water, Aloe Pure, Peaceful Sleep, Green Envy, ACAI Extra, ACAI Daily Cleanse and Wheatgrass, and offers other products, and Other Nutraceutical Businesses, which includes the operations of The Vitamin Factory, IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. Its customers are located in the United States, Luxembourg and Canada.

INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP) Recent Trading Information

INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP) closed its last trading session down -0.047 at 0.180 with 534,300 shares trading hands.

An ad to help with our costs